What are the recommendations for monitoring and treating pre-eclampsia and timing of birth made in 2019?
The 2019 recommendations for monitoring and treating pre-eclampsia and timing of birth include discussing with the anaesthetic and neonatal teams if birth is planned in a woman with pre-eclampsia and neonatal complications are anticipated, offering intravenous magnesium sulfate and a course of antenatal corticosteroids if indicated if early birth is planned for women with preterm pre-eclampsia, and deciding on timing of birth in women with pre-eclampsia as recommended in Table 3, which states that before 28 weeks of pregnancy, surveillance should be continued unless there are indications for planned early birth, and if between 28 and 37 weeks, surveillance should continue but a course of antenatal corticosteroids should be considered, and if 38 weeks and onwards, birth should be initiated within 24-48 hours. 